Skip to content
  • Contact
  • Twitter ( Cnr_Ibbc )
    IBBC
    • About
      • Institute   >
        • Mission
        • Naples Site
        • Monterotondo Site
      • Organizational chart
      • Director
      • IBBC Council
      • Researchers
      • Associated Researchers
      • Administration
      • Technicians
    • Research & Resources
      • Publications
      • Laboratories
      • Facilities
        • Mouse Clinic-EMMA facility
        • Facs Facility
        • Animal Models and Gene Therapy Core
      • Startup and Technology Tranfer
    • Topics
    • Education
    • News
      • Latest News and Events
      • Seminars
    • Jobs and Tenders
    • Utilities
      • IBBC webmail
      • CNR webmail
      • CNR Biblioproxy
      • CNR ePas
      • CNR Siper
      • GARR Filesender

    Molecular Neuro-Oncology

    • Home
    • Research Applications
    • Molecular Neuro-Oncology

    Group Leader : Maria Laura Falchetti
    Topic: Molecular oncology and pathology


     

    The research focus of our lab is the brain tumor glioblastoma (GBM). Our research has evolved over time, but the characterizing red trail has always been GBM. We studied different aspects, some dealing with GBM tumor biology, others are therapy-oriented. GBM is the most aggressive brain tumor in the adults, and, despite all the efforts spent by the scientific community, its prognosis remains poor, with a median survival at diagnosis of about 14 months. The main histological features of GBM tumors are massive necrosis and prominent angiogenesis. Angiogenesis represents a distinctive peculiarity of GBM, and a landmark for diagnosis. Anti-angiogenic treatments targeting tumor vasculature are considered the new frontier in GBM therapy but, unfortunately, they are substantially disappointing the expectations. The most recent research published by our group characterizes GBM tumor response to the anti-angiogenic drug axitinib. We demonstrated that this small tyrosine kinase inhibitor triggers cell senescence in both tumor as well as endothelial cells, but according to different molecular mechanisms. This finding opens the way to tumor cell-specific treatments and our future will be strongly oriented in this direction. We are currently launching a molecular study for unravelling the molecular mechanisms of GBM response to regorafenib, a multikinase inhibitor which is performing well in relapsed GBM patients.  Further, we are participating in an ongoing study on the possibility of using functionalized liposomes as specific delivery vehicles to central nervous system for gene therapy.


    Key Pubblications

     

    Falchetti ML et al (2003). Glioblastoma induces vascular endothelial cells to express telomerasein vitro. Cancer Res 63(13):3750-4. PMID: 12839970

    Pallini R et al (2006). Telomerase inhibition by stable RNA interference impairs tumor growthand angiogenesis in glioblastoma xenografts. Int J Cancer doi: 10.1002/ijc.21613

    Pacioni S et al (2017). Human mesenchymal stromal cells inhibit tumor growth in orthotopicglioblastoma xenografts. Stem Cell Res Ther (doi: 10.1186/s13287-017-0516-3).

    Mongiardi MP et al (2019.) Axitinib exposure triggers endothelial cells senescence through ROSaccumulation and ATM activation. Oncogene (doi: 10.1038/s41388-019-0798-2.)

    Pacioni S et al (2019). Brain Invasion along Perivascular Spaces by Glioma Cells: Relationshipwith Blood-Brain Barrier. Cancers (doi: 10.3390/cancers12010018)

     

    Research Group


     

    Researchers:
    Maria Patrizia Mongiardi
    email. mariapatrizia.mongiardi@cnr.it
    tel. 06 90091401 
    Andrea Levi 
    email. andrea.levi@cnr.it
    tel. 06 90091489 


    Post-doctoral fellows:         
    Maurizia Piras
    email. maurizia.piras@ibbc.cnr.it 
    tel. 06 90091467


    Graduate student:
    Matilde Merolle
    email. matildemerolle@live.it
    tel.06 90091467


    Collaborators:
    Prof. Roberto Pallini (Università Cattolica del Sacro Cuore)
    Dott.ssa Lucia Ricci Vitiani (Istituto Superiore di Sanità)
    Prof.ssa Manuela Helmer Citterich (Università di Tor Vergata)
    Dott.ssa Giovanna Mancini (Istituto per i Sistemi Biologici-CNR)
    Dott.ssa Manuela Pellegrini

     

    Napoli site

    Via Pietro Castellino 111 – 80131
    Naples
    tel. 0816132247 – Fax. 0816132547

    Monterotondo Site

    Via E. Ramarini, 32 – 00015 Monterotondo Scalo, Rome
    tel: +39 06 90091208

    Main Menù

    • Home
    • Research and Resources
    • Topics
    • Education
    • News
    • Jobs
    • Privacy and Cookie Policy

    RSS From CNR

    • GIFFONI IMPACT 2025 EREDITÀ CULTURALE E DIVENTARE UMANI La responsabilità delle comunità nella cura del patrimonio
    • Replication of a complex viral DNA element by eukaryotic proteins
    • World Economic History Congress - WEHC 2025

    Transparent administration

    Site contacts

    • Webmaster and developer: Fabio Concilio
    • For suggestions: web@ibbc.cnr.it

    IBBC - CNR Copyright © 2025 All rights reserved